Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-12-004945
Filing Date
2012-05-14
Accepted
2012-05-14 11:10:34
Documents
12
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q geovax_10q-033112.htm 10-Q 403132
2 EXHIBIT 10.1 ex10-1.htm EX-10.1 32532
3 EXHIBIT 31.1 ex31-1.htm EX-31.1 14461
4 EXHIBIT 31.2 ex31-2.htm EX-31.2 14420
5 EXHIBIT 32.1 ex32-1.htm EX-32.1 6111
6 EXHIBIT 32.2 ex32-2.htm EX-32.2 5256
  Complete submission text file 0001437749-12-004945.txt   1537356

Data Files

Seq Description Document Type Size
7 govx-20120331.xml EX-101.INS 131527
8 govx-20120331.xsd EX-101.SCH 13957
9 govx-20120331_cal.xml EX-101.CAL 18747
10 govx-20120331_def.xml EX-101.DEF 68839
11 govx-20120331_lab.xml EX-101.LAB 91253
12 govx-20120331_pre.xml EX-101.PRE 70279
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA 2Q 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA 2Q 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52091 | Film No.: 12837080
SIC: 8731 Services-Commercial Physical & Biological Research